Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cepheid (CPHD): What Smart Money Thinks about This Stock?

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund positions. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards Cepheid (NASDAQ:CPHD).

Is Cepheid (NASDAQ:CPHD) a buy here? Money managers are getting more bullish, as the number of bullish hedge fund positions advanced by 16 in recent months. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as New Gold Inc. (USA) (NYSEAMEX:NGD), Visteon Corp (NYSE:VC), and Laredo Petroleum Holdings Inc (NYSE:LPI) to gather more data points.

Follow Cepheid (NASDAQ:CPHD)
Trade (NASDAQ:CPHD) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

lab, scientist, tech, chemistry, test, experiment, reaction, pharmaceutical, medical, liquid, fluid, dropper, tool, pharmacology, sample, organic, pipette, drug, chemist, bio


With all of this in mind, let’s go over the recent action encompassing Cepheid (NASDAQ:CPHD).

What have hedge funds been doing with Cepheid (NASDAQ:CPHD)?

A total of 33 funds tracked by Insider Monkey were bullish on Cepheid at the end of the third quarter, up by 94% from the end of June. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of noteworthy hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).
According to Insider Monkey’s hedge fund database, Brian Taylor’s Pine River Capital Management has the most valuable position in Cepheid (NASDAQ:CPHD), worth close to $74.5 million, comprising 1.3% of its total 13F portfolio. The second most bullish fund is Alec Litowitz and Ross Laser’s Magnetar Capital, with a $74.1 million position; the fund has 1.1% of its 13F portfolio invested in the stock. Some other professional money managers with similar optimism contain Robert Emil Zoellner’s Alpine Associates, Carl Tiedemann and Michael Tiedemann’s TIG Advisors, and Isaac Corre’s Governors Lane. All these investors assembled their stakes during the third quarter

On the next page, we are going to see how the hedge fund sentiment towards Cepheid compares with other stocks.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.